Acute Lymphoblastic Leukemia Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
Recruiting
  • Leukemia
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-04-07
    Apr 7, 2022
    S
    Continuous Ambulatory Monitoring to Predict Elevated Risk of Infection in Children With Lymphoblastic Leukemia Undergoing Induction Chemotherapy (CAMPER-ALL)
    Recruiting
    • Acute Lymphoblastic Leukemia
    • Wearable Sensors
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    2022-04-07
    Apr 7, 2022
    N
    Biology Studies of Hematologic Cancers
    Enrolling by invitation
    • Acute Lymphoblastic Leukemia
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2022-04-07
      Apr 7, 2022
      M
      Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation
      Recruiting
      • Acute Lymphoblastic Leukemia
      • +3 more
      • Allogeneic Bone Marrow Transplantation
      • +10 more
      • Houston, Texas
        M D Anderson Cancer Center
      2022-03-31
      Mar 31, 2022
      N
      Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies - 2022
      Completed
      • Acute Lymphoblastic Leukemia
      • +5 more
      • Radiation
      • +3 more
      • New Hyde Park, New York
        Cohen Children's Medical Center
      2022-04-06
      Apr 6, 2022
      O
      CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies
      Recruiting
      • Acute Lymphoblastic Leukemia
      • +2 more
      • CLIC-1901
      • Vancouver, British Columbia, Canada
      • +1 more
      2022-03-26
      Mar 26, 2022
      N
      Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy - 2022
      Completed
      • Acute Myelogenous Leukemia
      • +6 more
      • This is a non-interventional study
      • Bakersfield, California
      • +19 more
      2022-04-04
      Apr 4, 2022
      U
      Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab
      Recruiting
      • Myelodysplastic Syndromes
      • +2 more
      • Ann Arbor, Michigan
        University of Michigan Cancer Center
      2022-03-31
      Mar 31, 2022
      F
      Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes
      Recruiting
      • Acute Biphenotypic Leukemia
      • +5 more
      • Ex-Vivo Expanded Cord Blood Progenitor Cell Infusion
      • +6 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      2022-03-31
      Mar 31, 2022
      G
      Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment
      Recruiting
      • Acute Lymphoblastic Leukemia
      • Lymphoblastic Lymphoma
      • Frankfurt (Main), Germany
        University Hospital of Frankfurt (Main)
      2022-04-01
      Apr 1, 2022
      T
      Reduced-Intensity Conditioning for the Prevention of Treatment-Related Mortality in Patients Who Undergo a Hematopoietic Stem Cell Transplant
      Recruiting
      • Acute Lymphoblastic Leukemia
      • +15 more
      • Hematopoietic Cell Transplantation
      • +7 more
      • Philadelphia, Pennsylvania
        Sidney Kimmel Cancer Center at Thomas Jefferson University
      2022-04-01
      Apr 1, 2022
      C
      Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States
      Recruiting
      • Acute Lymphoblastic Leukemia
      • Electronic Health Record Review
      • +2 more
      • Oakland, California
        Kaiser Permanente-Oakland
      2022-03-21
      Mar 21, 2022
      F
      HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
      Recruiting
      • Juvenile Myelomonocytic Leukemia
      • +27 more
      • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
      • +2 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      2022-03-16
      Mar 16, 2022
      S
      Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL - 2018
      Terminated
      • Acute Myelogenous Leukemia
      • +2 more
      • Oklahoma City, Oklahoma
      • +1 more
      2022-03-17
      Mar 17, 2022
      M
      Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
      Not yet recruiting
      • Chronic Lung Disease
      • +3 more
      • Physical activity
      • (no location specified)
      2022-03-25
      Mar 25, 2022
      C
      Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT
      Recruiting
      • Acute Myeloid Leukemia
      • +3 more
      • Ex-vivo expanded γδ T cell infusion
      • Beijing, China
        Chinese PLA General Hospital
      2022-03-24
      Mar 24, 2022
      S
      Cognitive Intervention at the End of Therapy for Survivors of Childhood ALL Treated on TOTXVI - 2021
      Completed
      • Acute Lymphoblastic Leukemia
      • Cognitive training
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      2022-03-24
      Mar 24, 2022
      C
      Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
      Recruiting
      • Acute Lymphoblastic Leukemia
      • +3 more
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • +21 more
      • Birmingham, Alabama
      • +218 more
      2022-03-25
      Mar 25, 2022
      J
      A Study of JNJ-75276617 in Participants With Acute Leukemia
      Recruiting
      • Acute Leukemias
      • +2 more
      • Duarte, California
      • +26 more
      2022-03-24
      Mar 24, 2022
      N
      Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow - 2020
      Completed
      • Myeloproliferative Disorders
      • +4 more
      • T-cell replete PBPC allograft
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2022-03-24
      Mar 24, 2022
      C
      Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
      Active, not recruiting
      Has Results
      • Acute Lymphoblastic Leukemia
      • +3 more
      • Birmingham, Alabama
      • +169 more
      2022-03-23
      Mar 23, 2022
      U
      Programmed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and Lymphoma
      Withdrawn
      • Acute Lymphoblastic Leukemia
      • +2 more
      • PACE CART19
      • (no location specified)
      2022-03-09
      Mar 9, 2022
      C
      Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
      Active, not recruiting
      • Acute Lymphoblastic Leukemia
      • Cytology Specimen Collection Procedure
      • Laboratory Biomarker Analysis
      • Birmingham, Alabama
      • +243 more
      2022-03-23
      Mar 23, 2022
      C
      Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
      Suspended
      • Acute Lymphoblastic Leukemia
      • Discussion
      • +2 more
      • Anchorage, Alaska
      • +481 more
      2022-03-22
      Mar 22, 2022
      S
      Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
      Active, not recruiting
      • Acute Lymphoblastic Leukemia
      • Los Angeles, California
      • +17 more
      2022-03-21
      Mar 21, 2022